Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas. (Q54249734)

26 May 2018

title

Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas. (English)

1 reference

26 May 2018

author

Marc-Henri Stern

15

1 reference

26 May 2018

Dominique Stoppa-Lyonnet

14

Dominique Stoppa-Lyonnet

1 reference

26 May 2018

12

Anne Vincent-Salomon

1 reference

PubMed ID

26317927

26 May 2018

Virginie Caux-Moncoutier

5

Virginie Caux-Moncoutier

1 reference

26 May 2018

Lisa Golmard

6

Lisa Golmard

1 reference

26 May 2018

Odette Mariani

9

Odette Mariani

1 reference

26 May 2018

Claude Houdayer

13

Claude Houdayer

1 reference

26 May 2018

Brigitte Sigal-Zafrani

10

Brigitte Sigal-Zafrani

1 reference

26 May 2018

author name string

Elodie Manié

1

1 reference

26 May 2018

Tatiana Popova

2

1 reference

26 May 2018

Aude Battistella

3

1 reference

26 May 2018

Julien Tarabeux

4

1 reference

26 May 2018

Nicholas K Smith

7

1 reference

26 May 2018

Christopher R Mueller

8

1 reference

26 May 2018

Thierry Dubois

11

1 reference

26 May 2018

language of work or name

English

0 references

publication date

24 September 2015

1 reference

26 May 2018

International Journal of Cancer

published in

1 reference

26 May 2018

volume

138

1 reference

26 May 2018

issue

4

1 reference

26 May 2018

page(s)

891-900

1 reference

26 May 2018

Meta-analysis of BRCA1 and BRCA2 penetrance

cites work

1 reference

Gene-panel sequencing and the prediction of breast-cancer risk

21 January 2018

1 reference

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

21 January 2018

1 reference

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

21 January 2018

1 reference

BRCA1 and BRCA2: different roles in a common pathway of genome protection

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer

21 January 2018

1 reference

Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications

21 January 2018

1 reference

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

Opportunities and hurdles in the treatment of BRCA1-related breast cancer

21 January 2018

1 reference

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

21 January 2018

1 reference

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

21 January 2018

1 reference

Breast-cancer risk in families with mutations in PALB2

21 January 2018

1 reference

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

Germline mutation in the RAD51B gene confers predisposition to breast cancer

21 January 2018

1 reference

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

21 January 2018

1 reference

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

21 January 2018

1 reference

Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.

21 January 2018

1 reference

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

21 January 2018

1 reference

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation

21 January 2018

1 reference

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents

21 January 2018

1 reference

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

21 January 2018

1 reference

Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

21 January 2018

1 reference

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

21 January 2018

1 reference

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

21 January 2018

1 reference

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

21 January 2018

1 reference

Germline BAP1 mutations predispose to renal cell carcinomas

21 January 2018

1 reference

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

21 January 2018

1 reference

Search for a gene expression signature of breast cancer local recurrence in young women

21 January 2018

1 reference

Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas

21 January 2018

1 reference

Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

21 January 2018

1 reference

Enhanced mismatch mutation analysis: simultaneous detection of point mutations and large scale rearrangements by capillary electrophoresis, application to BRCA1 and BRCA2.

21 January 2018

1 reference

Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model

21 January 2018

1 reference

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

21 January 2018

1 reference

Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer

21 January 2018

1 reference

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

Regulation of homologous recombination in eukaryotes

21 January 2018

1 reference

The shortest path is not the one you know: application of biological network resources in precision oncology research

21 January 2018

1 reference

The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis

21 January 2018

1 reference

Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatment.

21 January 2018

1 reference

The genetic epidemiology of breast cancer genes

21 January 2018

1 reference

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population

21 January 2018

1 reference

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

21 January 2018

1 reference

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29829

1 reference

26 May 2018

PubMed ID

26317927

1 reference

26 May 2018